-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
-
Everton winger Grealish set to miss rest of season in World Cup blow
-
Trump brands Minneapolis nurse killed by federal agents an 'agitator'
-
Arteta focuses on the positives despite Arsenal stumble
-
Fijian Drua sign France international back Vakatawa
-
Kevin Warsh, a former Fed 'hawk' now in tune with Trump
-
Zverev rails at Alcaraz timeout in 'one of the best battles ever'
-
Turkey leads Iran diplomatic push as Trump softens strike threat
-
Zelensky backs energy ceasefire, Russia bombs Ukraine despite Trump intervention
-
'Superman' Li Ka-shing, Hong Kong billionaire behind Panama ports deal
-
Skiing great Lindsey Vonn crashes at Crans-Montana, one week before Olympics
-
Slot warns Liverpool 'can't afford mistakes' in top-four scrap
-
Paris show by late Martin Parr views his photos through political lens
-
'Believing' Alcaraz outlasts Zverev in epic to reach maiden Melbourne final
-
Artist chains up thrashing robot dog to expose AI fears
-
Alcaraz outlasts Zverev in epic to reach maiden Australian Open final
-
French PM forces final budget through parliament
-
French-Nigerian artists team up to craft future hits
| SCS | 0.12% | 16.14 | $ | |
| RBGPF | 1.65% | 83.78 | $ | |
| BCC | -1.22% | 79.2 | $ | |
| NGG | -0.12% | 84.95 | $ | |
| GSK | 0.99% | 51.16 | $ | |
| CMSC | -0.02% | 23.69 | $ | |
| JRI | 0.15% | 12.975 | $ | |
| BP | 0.44% | 38.21 | $ | |
| RIO | -2.83% | 92.51 | $ | |
| BTI | -0.54% | 59.885 | $ | |
| RELX | -1.22% | 35.73 | $ | |
| BCE | 0.27% | 25.555 | $ | |
| CMSD | -0.04% | 24.05 | $ | |
| RYCEF | -2.69% | 16 | $ | |
| VOD | -0.41% | 14.65 | $ | |
| AZN | 0.29% | 92.855 | $ |
Yunu Extends from Site Imaging Standard to Central Review Workflow Leader
New Imaging Automation Delivers a Modern Framework for Central Review & Site Collaboration
CARY, NORTH CAROLINA / ACCESS Newswire / January 29, 2026 / As the clinical research industry looks toward SCOPE 2026, one reality remains clear: imaging has become increasingly essential to trial science, yet the operational models supporting it are reaching a breaking point. For years, clinical trial imaging has relied on fragmented systems, manual processes, and service-laden workarounds that no longer align with the quality, speed, and transparency requirements of sponsors.

Yunu is changing that equation. Built as a fit-for-purpose trial imaging platform, Yunu offers a tech-forward alternative that dramatically reduces project management work, eliminates delays, and accelerates the radiology reading process while keeping everyone connected, efficient, and informed.
From Fragmented Site-Central Practices to a Unified Standard
As the market share leader across NCI Comprehensive Cancer Centers, Yunu's rapid adoption has reshaped how imaging is performed and managed at scale. What began as a solution trusted by sites is now becoming a strategic platform for sponsors, who are increasingly adopting Yunu to bring greater rigor, confidence, and consistency into central review workflows. By embedding sponsor-specific requirements directly into workflow logic, Yunu's latest release brings the same efficient experience sites already rely on into the heart of trial imaging oversight.
The result is a single, shared environment where sites and sponsors operate with aligned standards, controlled visibility, and consistent execution, while reducing layers of coordination, dependency, and overhead. Yunu transforms trial imaging from a series of handoffs into a unified, end-to-end experience.
"Clinical trial imaging is breaking under the load of a combination of people, manual processes, and patchwork systems that hold it together," said Jeff Sorenson, Chief Executive Officer at Yunu. "Sponsors now recognize that the solution is not more outsourcing, but a thoughtful technology framework designed to carry more of the scientific and operational weight for them."
Engage with Yunu at SCOPE 2026
Yunu is signaling what comes next: a future where clinical trial imaging is powered by smart workflow, not manual effort. SCOPE Annual Summit attendees can meet with Yunu leadership and trial imaging experts at exhibit #201 in Orlando, Florida, February 2nd-5th, 2026.
About Yunu
Yunu is a clinical imaging data platform transforming how life sciences organizations manage, share, and analyze imaging data for clinical trials. Designed to meet the highest standards of compliance and collaboration, Yunu enables faster, cleaner, and more transparent imaging workflows from site to submission across a growing global community using Yunu every day. For more information, visit yunu.io and Request a Demo.
Contact:
Lindsay Fleming
Chief Marketing Officer
[email protected]
SOURCE: Yunu
View the original press release on ACCESS Newswire
J.Gomez--AT